Recombinant Human N-Acetylglucosaminyltransferase 3/MGAT3 CF

R&D Systems | Catalog # 7359-GT

R&D Systems
Loading...

Key Product Details

  • R&D Systems CHO-derived Recombinant Human N-Acetylglucosaminyltransferase 3/MGAT3 CF (7359-GT)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

CHO

Accession Number

Applications

Enzyme Activity
Loading...

Product Specifications

Source

Chinese Hamster Ovary cell line, CHO-derived human N-Acetylglucosaminyltransferase III/MGAT3 protein
Tyr31-Val533, with a C-terminal 6-His tag

Purity

>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Tyr31

Predicted Molecular Mass

58 kDa

SDS-PAGE

42-54 & 64-70 kDa, reducing conditions

Activity

Measured by its ability to transfer N-Acetyl-alpha -D-glucosamine from UDP-N-Acetyl-alpha -D-glucosamine to a biantennary N-linked core pentasaccharide in a CD39L3 coupled assay.
The specific activity is >100 pmol/min/μg, as measured under the described conditions.

Formulation, Preparation, and Storage

7359-GT
Formulation Supplied as a 0.2 μm filtered solution in Tris, NaCl and Glycerol.
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -70 °C as supplied.
  • 3 months, -70 °C under sterile conditions after opening.

Background: N-Acetylglucosaminyltransferase III/MGAT3

Mannosylglycoprotein N-acetyl-glucosaminyltransferase 3 (MGAT3), also known as GnT-III, regulates the branching of N-glycans. By transferring a GlcNAc residue to the beta -linked mannose of the trimannosyl core of N-linked oligosaccharides MGAT3 produces a bisecting GlcNAc structure (1). Bisecting GlcNAc is involved in a number of biological events, including the suppression of metastasis of cancer cells through modification on integrins (2, 3, 4) and the reduction of hepatitis B virus replication in hepatoma cells (5). The effect of the bisecting GlcNAc on a cancer cell counteracts that of the beta 1,6-GlcNAc created by MGAT5 (4, 6). Although MGAT3 and MGAT5 are functionally related, there is no significant homology at their primary sequences. In addition, bisecting GlcNAc on human Ig antibodies enhances their effector functions (7). Transgenic mice over expressing MGAT3 had aberrant glycosylation on apolipoprotein B and developed fatty livers (8). The enzymatic activity of recombinant human MGAT3 was determined using a phosphatase-coupled glycosyltransferase assay (9).

References

  1. Ihara, Y. et al. (1993) J. Biochem. 113:692.
  2. Yoshimura, M. et al. (1995) Proc. Natl. Acad. Sci. USA 92:8754.
  3. Isaji T, et al. (2004) J. Biol. Chem. 279:19747.
  4. Sato, Y. et al. (2009) J. Biol. Chem. 284:11873.
  5. Miyoshi, E. et al. (1995) J. Biol. Chem. 270:28311.
  6. Gu, J. and Taniguchi, N. (2008) Cell Adh. Migr. 2:243.
  7. Stanley P. (2002) Biochim. Biophys. Acta. 1573:363.
  8. Ihara, Y. et al. (1998) Proc. Natl. Acad. Sci. USA 95:2526.
  9. Wu, Z.L. et al. (2011) Glycobiology 21:727.

Long Name

beta-1,4-Mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase

Alternate Names

GGNT3, GNT-III, GNT3

Entrez Gene IDs

4248 (Human); 17309 (Mouse); 29582 (Rat)

Gene Symbol

MGAT3

UniProt

Additional N-Acetylglucosaminyltransferase III/MGAT3 Products

Product Documents for Recombinant Human N-Acetylglucosaminyltransferase 3/MGAT3 CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human N-Acetylglucosaminyltransferase 3/MGAT3 CF

For research use only

Related Research Areas

Citations for Recombinant Human N-Acetylglucosaminyltransferase 3/MGAT3 CF

Customer Reviews for Recombinant Human N-Acetylglucosaminyltransferase 3/MGAT3 CF

There are currently no reviews for this product. Be the first to review Recombinant Human N-Acetylglucosaminyltransferase 3/MGAT3 CF and earn rewards!

Have you used Recombinant Human N-Acetylglucosaminyltransferase 3/MGAT3 CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Human N-Acetylglucosaminyltransferase 3/MGAT3 CF (7359-GT):

Materials
  • Buffer A: 25 mM MES, 5 mM MnCl2, pH 6.5
  • Buffer B: 100 mM Tris, 5 mM CaCl2, pH 7.5
  • Recombinant Human N-Acetylglucosaminyltransferase III/MGAT3 (rhMGAT3) (Catalog # 7359-GT)
  • Donor Substrate: UDP-GlcNAc (Sigma, Catalog # U4375), 50 mM stock in 50% ethanol
  • Acceptor Substrate: Biantennary N-Linked Core Pentasaccharide (V-Labs, Catalog # M592), 10 mM stock in deionized water
  • Glycosyltransferase Activity Kit (Catalog # EA001)
  • 96-well Clear Plate (Costar, Catalog # 92592)
  • Plate Reader (Model: SpectraMax Plus by Molecular Devices) or equivalent
  1. Dilute 1 mM Phosphate Standard provided by the Glycosyltransferase Kit by adding 40 µL of the 1 mM Phosphate Standard to 360 µL of Buffer A for a 100 µM stock.
  2. Prepare standard curve by performing six one-half serial dilutions of the 100 µM Phosphate stock in Buffer A. The standard curve has a range of 0.078 to 5 nmol per well.
  3. Dilute rhMGAT3 to 10 µg/mL in Buffer A.
  4. Dilute Donor Substrate to 1 mM in Buffer A.
  5. Dilute Acceptor Substrate to 1 mM in Buffer A.
  6. Prepare Substrate Mixture by combining 120 µL of 1 mM Donor Substrate, 120 µL of 1 mM Acceptor Substrate, and 60 µL of Buffer A.
  7. Load 50 µL of each dilution of the standard curve into a plate. Include a curve blank containing 50 μL of Buffer A.
  8. Load 25 µL of the 10 µg/mL rhMGAT3 into the plate. Include a Control containing 25 µL of Buffer A.
  9. Start the reaction by adding 25 µL of Substrate Mixture to the wells, excluding the standard curve.
  10. Cover the plate with a plate sealer and incubate at 37 °C for 20 minutes.
  11. Dilute Coupling Phosphatase 1 to 2 μg/mL in Buffer B.
  12. Add 50 µL of 2 µg/mL Coupling Phosphatase 1 to reaction wells and blanks, excluding the standard curve. Also, add 50 µL of Buffer B to the wells containing the standard curve.  Mix and incubate for 10 minutes at room temperature.
  13. Add 30 µL of the Malachite Green Reagent A to all wells.
  14. Add 50 µL of deionized water to all wells.
  15. Add 30 µL of the Malachite Green Reagent B to all wells. Mix and incubate for 20 minutes at room temperature.
  16. Read plate at 620 nm (absorbance) in endpoint mode.
  17. Calculate specific activity:

     Specific Activity (pmol/min/µg) =

Phosphate released* (nmol) x (1000 pmol/nmol)
Incubation time (min) x amount of enzyme (µg)

     *Derived from the phosphate standard curve using linear or 4-parameter fitting and adjusted for Control.

Per Well:

  • rhMGAT-3: 0.25 µg
  • Coupling Phosphatase 1: 0.1 µg
  • Donor Substrate: 10 nmol
  • Acceptor Substrate: 10 nmol

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes